Skip to main content
CYDY
OTC Life Sciences

CytoDyn 获得 1750 万美元融资推进 Leronlimab 的开发

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$0.233
Mkt Cap
$307.556M
52W Low
$0.193
52W High
$0.447
Market data snapshot near publication time

summarizeSummary

CytoDyn Inc. 已经成功完成了一轮 1750 万美元的融资，这为公司提供了关键的资本注入。考虑到公司最近的 10-Q 文件，这一融资尤为重要，该文件强调了 "持续经营" 的警告、巨大的净亏损和 "严重的流动性状况"。这一融资直接解决了这些流动性问题，并专门用于继续开发 Leronlimab，该公司的主要药物候选物。对于交易者来说，这一事件提供了急需的运营跑道，并减少了立即的破产风险，使其成为一个重要的积极发展。焦点现在将转移到高效地部署这些资金，以推进 Leronlimab 的临床进展和改善公司的整体财务状况。

在该公告发布时，CYDY的交易价格为$0.23，交易所为OTC，所属行业为Life Sciences，市值约为$3.1亿。 52周交易区间为$0.19至$0.45。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed CYDY - Latest Insights

CYDY
Apr 22, 2026, 5:21 PM EDT
Filing Type: S-1
Importance Score:
8
CytoDyn Registers Over 278 Million Shares for Resale, Including Warrants, Amidst Going Concern Warning
Sentiment: Negative
View Wiseek Article
CYDY
Apr 08, 2026, 5:15 PM EDT
Filing Type: 424B3
Importance Score:
9
CytoDyn Registers 376M Shares for Resale Amidst Ongoing Dilutive Financings and Reiterated Going Concern Warning
Sentiment: Negative
View Wiseek Article
CYDY
Apr 08, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
CytoDyn Reports Deep Losses, Ongoing Going Concern, & Significant Dilutive Financing
Sentiment: Negative
View Wiseek Article
CYDY
Mar 25, 2026, 5:16 PM EDT
Filing Type: 424B3
Importance Score:
8
Prospectus Supplement Enables Resale of 376M Shares, Incorporates Debt Extension with Stock Payments
Sentiment: Negative
View Wiseek Article
CYDY
Mar 24, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
CytoDyn Extends $57M Convertible Notes Maturity by 3 Years, Agrees to $1M Monthly Stock Payments
Sentiment: Neutral
View Wiseek Article
CYDY
Mar 09, 2026, 5:15 PM EDT
Filing Type: 424B3
Importance Score:
8
CytoDyn Registers 376 Million Shares for Resale, Enabling Significant Dilution from Recent Financing
Sentiment: Negative
View Wiseek Article
CYDY
Mar 05, 2026, 8:35 AM EST
Filing Type: 8-K
Importance Score:
8
CytoDyn Secures $18.8M in Dilutive Equity Financing to Address Liquidity Concerns
Sentiment: Neutral
View Wiseek Article
CYDY
Mar 05, 2026, 8:31 AM EST
Source: Reuters
Importance Score:
8
CytoDyn Secures $17.5M Financing to Advance Leronlimab Development
Sentiment: Positive
View Wiseek Article
CYDY
Jan 09, 2026, 5:15 PM EST
Filing Type: 424B3
Importance Score:
9
CytoDyn Issues Going Concern Warning, Settles Lawsuit with Significant Share Dilution
Sentiment: Negative
View Wiseek Article
CYDY
Jan 09, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
9
CytoDyn Reports Substantial Losses, Going Concern Doubt, and Highly Dilutive Legal Settlement
Sentiment: Negative
View Wiseek Article